1. Anti‑tumor effects of anti‑epileptic drugs in malignant glioma cells
   Chihiro Yagi et al, 2022, Oncol Rep CrossRef
2. Perampanel in adjunctive therapy of patients with brain tumor-related epilepsy: real-world data
   G. G. Samsonova et al, 2023, Èpilepsiâ paroksizmalʹnye sostoâ. CrossRef
3. Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review
   Payam Tabaee Damavandi et al, 2023, Brain Sciences CrossRef
4. Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits
   Manuela Stella et al, 2023, Biomedicines CrossRef
5. Ligand-Gated Ion Channels: Prognostic and Therapeutic Implications for Gliomas
   Grace Hey et al, 2023, JPM CrossRef
6. The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy
   Fabio Perversi et al, 2023, Front. Neurol. CrossRef
7. The evaluation of six genes combined value in glioma diagnosis and prognosis
   Ping Lin et al, 2023, J Cancer Res Clin Oncol CrossRef
8. Intrinsic and Microenvironmental Drivers of Glioblastoma Invasion
   Emerson De Fazio et al, 2024, IJMS CrossRef
9. Neuroprotective strategies for neonatal hypoxic-ischemic brain damage: Current status and challenges
   Qing You et al, 2023, European Journal of Pharmacology CrossRef
10. Perampanel for Treatment of People with a Range of Epilepsy Aetiologies in Clinical Practice: Evidence from the PERMIT Extension Study
    Adam Strzelczyk et al, 2024, Neurol Ther CrossRef
11. Gliomagenesis, Epileptogenesis, and Remodeling of Neural Circuits: Relevance for Novel Treatment Strategies in Low- and High-Grade Gliomas
    Alessandro Grimi et al, 2024, IJMS CrossRef
12. Prospects for the use of perampanel in the treatment of epilepsy in patients with malignant gliomas of the brain
    Yi Wang et al, 2024, Rev Clin Pharm Drug Ther CrossRef